Global Anal Fistula Treatment Market Size (2024 - 2029)

The anal fistula treatment market is projected to experience growth over the forecast period, driven by an increase in inflammatory bowel disease cases, the introduction of new products, and a rising demand for non-surgical treatment options. The market's expansion is further supported by technological advancements and the development of advanced drugs and devices aimed at providing safe and effective treatments with minimal side effects. However, the market's growth is somewhat hindered by the high costs associated with treatment and a general lack of awareness.

Market Size of Global Anal Fistula Treatment Industry

Anal Fistula Treatment Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 3.80 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Global Anal Fistula Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Anal Fistula Treatment Market Analysis

The anal fistula treatment market is expected to register a CAGR of 3.8% over the forecast period.

COVID-19 had a significant impact on the anal fistula treatment market. For instance, as per the article published in 2021 under the title 'Insights into the management of anorectal disease in the coronavirus 2019 disease era', during the COVID-19 pandemic, there was a delay in the treatment of anal fistula, which caused an uncomfortable situation for patients. In such cases, outpatient exploration with proctoscopy, and seton placement, were alternative options based on a previous study in Crohn's disease patients. Furthermore, as per the blog published in 2021 under the title 'Anal Fissure Cases On The Rise In Covid Era; Treatment is Must!', other than antibiotics, patients overdosing on vitamin, zinc tablets and herbal tonics exacerbated the symptoms of an existing fissure in the long run. Patients with no history of anal fissures also show symptoms of the condition due to these medications during COVID-19. According to the same source, the occurrence of anal fissures had been reported in patients who had previously received COVID-19 treatment. Hence, considering the above-mentioned factors, COVID-19 had a notable impact on the anal fistula treatment market.

The anal fistula treatment market is anticipated to show rapid growth due to the rising cases of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, the launch of new products, and growing demand for non-surgical methods such as fibrin glue injection, adipose-derived stem cells therapy. For instance, the research, which was carried out by scientists at the University of Nottingham and funded by Crohn's & Colitis UK and Coeliac UK in 2022 showed that the prevalence of Crohn's and Colitis in the United Kingdom (UK) population is far higher than previously thought. The same study reported that 1 in every 123 people in the UK have either Crohn's disease or ulcerative colitis. This amounts to a total of nearly half a million people in the UK living with inflammatory bowel disease (IBD). Therefore, although inflammatory bowel disease is not that common, it still impacts a significant amount of people in the UK.

In addition, there is a rise in demand for safe and effective treatment with no chance of recurrence and fewer side effects which is propelling the key industry players to introduce advanced drugs and devices. Additionally, the technological advancement in anal fistula treatment is boosting market growth. For instance, as per the article published in 2021 under the title 'Advances in the Treatment of Anal Fistula: A Mini-Review of Recent Five-Year Clinical Studies', several combined drainage Seton procedures (pulling Seton, electric-acoustic stimulation (EAS)-sparing Seton after rerouting, and rerouting Seton around the EAS combined with mucosal advancement flap) and LIFT-plug are considered viable therapy for complex anal fistulas. Such advancements in the field of anal fistula treatment are anticipated to boost market growth.

Hence, as per the factors mentioned above, the anal fistula treatment market is likely to witness growth over the forecast period. However, the high cost associated with the anal fistula treatment and lack of awareness regarding the anal fistula treatment restrain the market growth.

Anal Fistula Treatment Industry Segmentation

As per the scope of the report, an anal fistula is a tract between the epithelial surface of the rectum and the perianal area. There are several glands in the anus which sometimes get blocked or clogged. This leads to bacterial infection and results in swelling around the infected tissues. Anal fistula treatment, therefore, involves the use of both surgical and non-surgical approaches for the effective removal of anal fistulae in patients. The Anal Fistula Market is segmented by Treatment Type (Surgical and Non-Surgical), Application (Intersphincteric Fistula, Transsphincteric Fistula, Suprasphincteric Fistula, Others), End-User (Hospitals, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Treatment Type
Surgical
Non Surgical
By Application
Intersphincteric Fistula
Transsphincteric Fistula
Suprasphincteric Fistula
Others
By End User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Anal Fistula Treatment Market Size Summary

The anal fistula treatment market is poised for growth, driven by the increasing prevalence of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, alongside the introduction of innovative treatment options. The market is experiencing a shift towards non-surgical methods, including fibrin glue injections and adipose-derived stem cell therapy, which are gaining traction due to their potential for fewer side effects and reduced recurrence rates. Technological advancements in treatment procedures, such as combined drainage Seton techniques and LIFT-plug therapies, are further propelling market expansion. Despite the challenges posed by the COVID-19 pandemic, which delayed treatments and exacerbated symptoms in some patients, the market is expected to recover and grow, supported by ongoing research and development efforts.

North America is anticipated to lead the anal fistula treatment market, bolstered by a substantial patient population with inflammatory bowel diseases and a high rate of healthcare expenditure. The region's early adoption of new technologies and significant research initiatives, such as those conducted by Ossium Health and Cleveland Clinic, are expected to enhance market growth. The fragmented nature of the market, with numerous global and regional players actively engaging in product launches and collaborations, is contributing to competitive dynamics. Key industry participants, including Medtronic plc, KARL STORZ SE & Co. KG, and Biolitec AG, are focusing on expanding their market share through innovative solutions and strategic partnerships. Despite the high costs and limited awareness of anal fistula treatments, the market is set to grow, driven by the demand for effective and safe treatment options.

Explore More

Global Anal Fistula Treatment Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Cases of Inflammatory Bowel Diseases (IBD) Such As Crohn's Disease and Ulcerative Colitis

      2. 1.2.2 Launch of New Products

      3. 1.2.3 Growing Demand of Non-Surgical Methods Such as Fibrin Glue Injection, Adipose-derived Stem Cells Therapy

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost Associated With the Procedure

      2. 1.3.2 Lack of Awareness about Anal Fistula Treatment

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Treatment Type

      1. 2.1.1 Surgical

      2. 2.1.2 Non Surgical

    2. 2.2 By Application

      1. 2.2.1 Intersphincteric Fistula

      2. 2.2.2 Transsphincteric Fistula

      3. 2.2.3 Suprasphincteric Fistula

      4. 2.2.4 Others

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Anal Fistula Treatment Market Size FAQs

The Global Anal Fistula Treatment Market is projected to register a CAGR of 3.80% during the forecast period (2024-2029)

Medtronic plc, KARL STORZ SE & Co. KG, Biolitec AG, Surtex Instruments Limited and Cook Group (Cook Medical) are the major companies operating in the Global Anal Fistula Treatment Market.

Anal Fistula Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)